A patient who has BPH is taking doxazosin and finasteride. The ...

[Evvie72]

A patient who has BPH is taking doxazosin and finasteride. The patient asks the primary care NP whether he has an increased risk of prostate cancer. The NP should tell him:
 
  a. his overall cancer risk is increased.
  b. he has an increased risk of a certain type of cancer.
  c. his cancer risk is the same as any other man his age.
  d. doxazosin will increase his cancer risk, but only slightly.

Question 2

A patient who has BPH is taking alfuzosin (Uroxatral) and finasteride (Proscar). The patient has had two urinary tract infections (UTIs) in the past 2 months. A urinalysis in the clinic is negative for leukocyte esterase but positive for hematuria.
 
  The primary care NP should: a. discontinue finasteride.
  b. refer the patient to a urologist.
  c. change alfuzosin to tamsulosin.
  d. add doxazosin to the drug regimen.

[Amiracle]

Answer to Question 1

B
There is an overall reduction in prostate cancer risk for patients taking 5b-reductase inhibitors, such as finasteride, but there is an increased risk of high-grade prostate cancer. His overall cancer risk is less. Doxazosin does not affect cancer risk.

Answer to Question 2

B
Surgery is indicated for patients who are refractory to treatment with medications or who have recurrent UTIs or hematuria. The NP should refer the patient to a urologist. All b-blockers are considered equally efficacious, so changing the drug regimen is not indicated.

[Evvie72]

Thanks

[Amiracle]

Welcome